SCHEMBL13951010

SCHEMBL13951010

C/C(=C\N=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 3/20 0.43
▸ CES1 P23141 3/20 0.43
▸ KDM1A O60341 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.40
▸ DEGS1 O15121 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ DAO P14920 1/20 0.39
▸ NAPRT Q6XQN6 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28185604 0.78 CES2 (0.43) CES2CES1MAPTCYP1A2CA1
SCHEMBL21242007 0.77 KDM1A (0.41) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL4864700 0.77 CES2 (0.39) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL7953691 0.77 CES2 (0.39) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL11107135 0.77 CES2 (0.39) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL22357532 0.76 ALDH1A1 (0.43) CES2CES1NFE2L2MAPTCYP1A2
SCHEMBL14050035 0.74 CYP2C19 (0.48) CES2CES1MAPTCYP1A2HSD17B10
SCHEMBL29058948 0.73 CES2 (0.48) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL20227851 0.72 DEGS1 (0.47) CES2CES1KDM1ANFE2L2DEGS1
SCHEMBL23458237 0.72 KDM1A (0.48) CES2CES1KDM1ADEGS1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048451-A1 Synthesis of triazole derivatives from Lewis base mediated nitroalkene-aldehyde coupling WEST VIRGINIA UNIVERSITY 2009-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048451-A1 Synthesis of triazole derivatives from Lewis base mediated nitroalkene-aldehyde coupling NOX3, NEU3, ADH5 CES2 1274/4885CES1 2401/4885KDM1A 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback